Novartis, company culture and COVID-19: the pharmaphorum podcastNovartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face Share XNovartis, company culture and COVID-19: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-company-culture-covid-19/
Amgen and science education: the pharmaphorum podcastHarvard University launched LabXchange in January and the free science education platform has acquired new resonance during the Share XAmgen and science education: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/amgen-labxchange-harvard-science-education/
UK pharma leadership and COVID-19: the pharmaphorum podcastThe COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure Share XUK pharma leadership and COVID-19: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/uk-pharma-leadership-covid-19/
Learning from China’s COVID-19 experience – the Health Heroes podcastThe second episode of Kantar’s Health Heroes podcast considers what can be learnt from China’s experience of the Share XLearning from China’s COVID-19 experience – the Health Heroes podcasthttps://pharmaphorum.com/podcast/china-experience-covid-19-pandemic/
Eisai and Alexa skills in epilepsy: the pharmaphorum podcastVoice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world Share XEisai and Alexa skills in epilepsy: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/eisai-alexa-skills-epilepsy/
Digital health and interoperability: the pharmaphorum podcastOne of the biggest barriers to applying precision medicine to clinical trials and patient engagement is getting different Share XDigital health and interoperability: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/seqster-digital-health-interoperability/
Understanding the impact of a rare disease – the Health Heroes podcastEpisode one of Kantar’s Health Heroes podcast looks at caregiving challenges for Gaucher disease and how patient registries Share XUnderstanding the impact of a rare disease – the Health Heroes podcasthttps://pharmaphorum.com/podcast/health-heroes-podcast-rare-disease-impact/
Roche, big data and patient outcomes: the pharmaphorum podcastIn the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data Share XRoche, big data and patient outcomes: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/roche-big-data-and-patient-outcomes/
Pfizer and the UK cancer landscape: the pharmaphorum podcastPfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK Share XPfizer and the UK cancer landscape: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pfizer-uk-nhs-cancer/
